SIRT2 and neurodegenerative disease: So far, the results obtained in our study supported the central beneficial effects of SIRT2 inhibition in AD; however, to date, none of the published studies regarding the potential interest of SIRT2 inhibition in neurodegenerative diseases has assessed the peripheral consequences of this treatment.